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Objective: We evalutated long term clinical outcome in patients post corpus cavernosum-corpus spongiosum shunt (Al-Ghorab shunt) plus intracavernous tunneling (CC-CSS + ICT) for prolonged ischemic priapism (PIP). Methods: Forty two patients post CC-CSS + ICT for PIP were treated in Andrology Center, Peking University First Hospital, Peking University during 2007 to 2014, then were followed up and evaluated using International Index of Erectile Function (IIEF), and quality of life (QOL) questionary form and color duplex Doppler ultrasonography (CDDU) and urinary flows. Results: Thirty eight patients (90.1%) were followed up with the mean age of 41±9.2 years old and with the mean duration of follow up of 46±7.8 months. The response to PDE5i was evaluated also. All patients severe corpus cavernosum fibrosis were evaluated by CDDU without severe penile curvature and urinary dysfunction. However, all patients were suffered from erectile dysfunction with significantly decreased QOL. Only three cases (8%) were responded to PDE5i treatment, and eight cases (21%) were successfully treated by penile prosthesis implantation. Conclusions: These results suggested that the CC-CSS + ICT could quickly reduce penile rigidity and pain of PIP, however, erectile dysfunction due to sever corpus carvernosum fibrosis post CC-CSS + ICT significantly influence QOL of patients and penile prosthesis implantation is a safe and effective method for treating ED for post CC-CSS + ICT. AB235. The correlation studies of mood disorders and testosterone deficiency in young men
